
Sign up to save your podcasts
Or
Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.
4.4
105105 ratings
Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.
110 Listeners
75 Listeners
93 Listeners
1,711 Listeners
893 Listeners
191 Listeners
754 Listeners
142 Listeners
73 Listeners
72 Listeners
51 Listeners
55 Listeners
69 Listeners
154 Listeners
325 Listeners
712 Listeners
134 Listeners
12 Listeners
195 Listeners
112 Listeners
242 Listeners
1,012 Listeners
38 Listeners
100 Listeners